Posted Oct. 2, 2017
The CRNBC board on Sept. 29 approved a change to the Nurse Practitioner scope of practice relating to prescribing controlled drugs and substances for self-injection by the client. The board approved removing the limit, “Nurse practitioners do not prescribe controlled drugs and substances for self-injection by the client” (p. 26 of Scope of Practice for NPs.)
There are three areas where this limit was creating a regulatory barrier that impacted client access to the most appropriate drug and route of medication administration:
- transgender care,
- opioid use disorder, and
- pain.
This change takes effect Nov. 1, 2017. The scope document will be updated accordingly.
Email
practice@crnbc.ca if you have questions.